| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | 0.0014 | 1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.0027 | 1 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | -0.00091 | 1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.00046 | 1 |